FDA approves new treatment for advanced lung cancer
Tuesday, October 6, 2015 - 07:00
in Health & Medicine
Stephen FellerSILVER SPRING, Md., Oct. 5 (UPI) -- The Food and Drug Administration approved a new drug for patients with advanced non-small cell lung cancer whose tumors have a specific genetic mutation.